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ABSTRACT
Background: Dyspepsia is one of the major indications for upper gastrointestinal 
endoscopy. Other indications include dysphagia, odynophagia and gastrointestinal 
bleeding. Endoscopy is an expensive procedure that is out of reach of many patients in 
resource constrained region such as western Kenya. We reviewed endoscopy records 
from both public and private health institutions spanning ten years.     
Objective: To determine the pattern of referral and endoscopy diagnoses in patients 
referred for upper gastrointestinal endoscopy in Eldoret, Kenya.  
Design: Retrospective chart review.
Setting: Moi Teaching and Referral Hospital, private hospitals and private clinics in 
Eldoret, Kenya
Subjects: One thousand six hundred and ninety (1690) Patients who underwent upper 
GI endoscopy from 1993 to 2003 were reviewed after obtaining clearances from the 
respective institutions. Information on age, sex, symptoms, and endoscopy diagnosis 
were extracted and subjected to statistical analysis. 
Results: The most common symptom was dyspepsia in 1059 (62.7%) followed by 
dysphagia in 224 (13.3%).  Others were referred with diagnosis of cancer of the stomach 
or oesophagus. Common endoscopy diagnoses were cancer of the oesophagus in 199 
(11.8%) and duodenal ulcer in 186 (11.0%).  The majority of the patients (30.4%) had 
normal endoscopy findings.  Of the 1059 patients with dyspepsia, only 154 (14.5%) 
had duodenal ulcer and 34 (3.2%) had gastric ulcers, the majority, 37.2% had normal 
endoscopy findings.   
Conclusion: Dyspepsia was main reason for referral, but the majority of such patients 
had normal findings. Cancer of the oesophagus was the main diagnosis in patients 
with dysphagia.  In view of the cost of endoscopy, only those with dyspepsia and 
alarm symptoms be referred for the procedure.  
INTRODUCTION
The first gastroscopy in 1868 is credited to 
Kussmaul (1). This was followed in the 1920s by the 
conceptualisation of image transmission using flexible 
quartz fibers a concept used by Hopkins in 1954 to 
build a model of a flexible fibre imaging device (2) 
the precursor of fibre-optic endoscope.  Since then 
endoscopes and endoscopy have undergone great 
technical developments to the current new dimension 
in imaging of endoscopic ultrasonography (EUS) 
by combining ultrasonography and endoscopy (3). 
These developments have enhanced the safety and 
diagnostic yield of endoscopy as well as providing 
therapeutic options making upper gastrointestinal 
endoscopy (UGIE) the most accurate and cost effective 
tool for evaluating patients with gastrointestinal 
related symptoms (4). Thus UGIE has become 
an established mode of investigation with added 
opportunity for treatment of a wide range of upper 
gastrointestinal conditions and biopsy of lesions for 
diagnosis (5).  
 Upper gastrointestinal (UGI) diseases are 
leading causes of morbidity and mortality globally. 
One of the major indications UGIE is dyspepsia. 
Dyspepsia is described as, a common symptom, 
that may be caused by a variety of conditions such 
as peptic ulcer disease (PUD), gastro-oesophageal 
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reflux (GORD) and malignancy (6, 7) among others. 
Other indications are dysphagia, odynophagia and 
gastrointestinal bleeding (7).  UGIE has been found 
to be both effective and a safe procedure that can 
be performed at large medical centres, small rural 
hospitals, outpatient clinics or even private offices 
(7).  
 Upper GI endoscopy (UGIE) was introduced in 
Eldoret in the early 1990’s (8), since then many patients 
have undergone the procedure, mainly for diagnostic 
purposes. However, the cost of the procedure is high 
and out of reach of many patients.  We therefore, 
reviewed endoscopy records to provide information 
on clinical indications for the procedure to guide care 
and inform referral of patients with GI symptoms 
by the care providers.  The objectives of this study 
were, first, to describe the age and sex distribution of 
patients referred for UGIE and secondly, to determine 




In this retrospective study we analysed the data 
from the records of patients who underwent upper 
GI endoscopy during ten years from May1993 to 
April 2003. All available records from both private 
and public services were studied and information 
regarding age, sex, symptoms, endoscopy diagnosis 
extracted and entered into a special data form before 
being entered into a computer by a trained research 
assistant.  Patients who underwent endoscopy more 
than once for the same complaint without intervening 
symptom-free period, were counted only once.  The 
procedures were performed using either video-scope 
or flexible fibre-optic upper GI scope.  
 SAS and Stata statistical software were used for 
data handling and analysis.  Means and proportions 
were calculated to describe the subjects.
Ethical considerations: To ensure confidentiality patient 
initials and a unique study number were used during 
data extraction.  This study was approved by Moi 
University School of Medicine (MUSOM) and Moi 
Teaching and Referral Hospital (MTRH) Institutional 
Research and Ethics Committee (IREC) as well as the 
administration of MTRH and the other institutions 
where patients underwent endoscopy.    
RESULTS
One thousand six hundred and ninety (1690) patients 
aged between 80 and 100   years (mean 45.9 ± 18.9, 
median 44 years) were referred and underwent 
upper GI endoscopy in the referral hospital (24.9%), 
private hospitals (0.4%) and private clinics (74.8%) 
in Eldoret, Kenya during the period under review. 
They comprised 864 (51%) males; mean age 45.9 ± 
19.2 (median 44.0 and range 12 to 100) years and 826 
(49%) females; mean age 45.9 ± 18.7 (median 44.0 
and range 8 to 100) years.  Age and sex distribution 
is shown in Table 1.
Table 1
Age and sex distribution of 1690 patients
Age groups  Male N (%)  Female N (%)  Total N (%)
=<25 142 (16.4%) 132 (16.0%) 274 (16.2%)
26-35 161 (18.6%) 155 (18.8%) 316 (18.7%)
36-45 155 (17.9%) 141 (17.1%) 296 (17.5%)
46-55 128 (14.8%) 114 (13.8%) 242 (14.3%)
56-65 120 (13.9%) 133 (16.1%) 253 (15.0%)
>65 158 (18.3%) 151 (18.3%) 309 (18.3%)
Total 864 826 1690
The most common symptom for referral was dyspepsia seen in 1059 (62.7%) of the patients, followed by 
dysphagia in 224 (13.3%).  Others were referred with diagnosis of cancer of the stomach or oesophagus. 
(The frequencies of symptoms for referral are shown (Table 2).
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Table 2
Reasons for referral (endoscopy)
Reason for referral (clinical diagnosis) Males n (%) Females n (%) All N (%)
Dyspepsia 505 (58.4) 554 (67.1) 1059 (62.7)
Heart burn 11 (1.3) 17 (2.1) 28 (1.7)
Vomiting 37 (4.3) 41 (5.0) 78 (4.6)
Combination 3 (0.3) 3 (0.4) 6 (0.4)
Ca oesophagus 42 (4.9) 19 (2.3) 61 (3.6)
Ca stomach 44 (5.1) 37 (4.5) 81 (4.8)
Unclear reasons 34 (3.9) 17 (2.1) 51 (3.0)
Vomiting blood 65 (7.5) 37 (4.5) 102 (6.0)
Dysphagia 123 (14.2) 101 (12.2) 224 (13.3)
Total 864 826 1690
Common endoscopy diagnoses were cancer of the oesophagus reported in 199 (11.8%) followed by duodenal 
ulcer in 186 (11.0%) of the patients.  Majority 513 (30.4%) had normal endoscopy findings (Table 3).
Table 3
Endoscopy diagnoses
Diagnosis Males n (%) Females n (%) All N (%)
Duodenal ulcer 116 (13.4) 70 (8.5) 186 (11.0)
Gastric ulcer 29 (3.4) 23 (2.8) 52 (3.1)
Duodenitis 42 (4.9) 43 (5.2) 85 (5.0)
Gastritis 70 (8.1) 72 (8.7) 142 (8.4)
Combination 27 (3.1) 21 (2.5) 48 (2.8)
Ca oesophagus 113 (13.1) 86 (10.40 199 (11.8)
Ca stomach 42 (4.9) 26 (3.1) 68 (4.0)
Normal 213 (24.7) 300 (36.3) 513 (30.4)
Reflux oesophagitis 66 (7.6) 67 (8.1) 133 (7.9)
Bile reflux 38 (4.4) 34 (4.1) 72 (4.3)
Pyloric stenosis 10 (1.2) 05 (0.6) 15 (0.9)
Deformed duodenal bulb 17 (2.0) 10 (1.20 27 (1.6)
Oesophageal varices 28 (3.2) 06 (0.7) 34 (2.0)
Others* 53 (6.1) 63 (7.6) 116 (6.9)
Total 864 826 1690
* Others included:  oesophageal candidiasis, oesophageal stenosis and other non specific conditions.
Among the 1059 patients referred with dyspepsia, only 
154 (14.5%) had duodenal ulcer, 34 (3.2%) had gastric 
ulcers and majority 37.2% had normal endoscopy 
findings.  Loglinear regression model (analysis) 
was used to determine the interaction of reason for 
referral and endoscopy diagnosis.   The interaction 
of each of all the levels and their associated p-values 
were obtained (Table 4).  It is noted that dyspepsia 
as a reason for endoscopy is significantly associated 
with duodenal ulcer and cancer of oesophagus 
(p<0.0001). It is also associated with gastric ulcer 
(p=0.0011). Dysphagia is also significantly associated 
with cancer of oesophagus (p<0.0001) and duodenal 
ulcer (p=0.0004).  
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Table 4























154 34 77 92 39 13 19 394 237 1059
14.54 3.21 7.27 8.69 3.68 1.23 1.79 37.20 23.38




3 1 0 1 0 1 0 12 10 28
10.71 3.57 0.00 3.57 0.00 3.57 0.00 42.86 35.71
0.0341 0.7693 0.8957 0.0015 0.3905 0.0065
Vomiting 3 1 2 19 3 7 7 16 20 78
3.85 1.28 2.56 24.36 3.85 8.97 8.97 20.51 25.64
0.11660 0.3567 0.2449 0.0002 0.1160 0.0001 0.1372 0.9770 0.0235
Combi-
nation
1 0 0 1 1 0 0 1 2 6
16.67 0.00 0.00 16.67 0.00 0.00 16.67 33.33
0.0534 0.2665 0.0634 0.7130 0.6518
Ca oeso-
phagus
0 1 0 2 0 40 5 6 7 61
0.00 1.64 0.00 3.28 0.00 65.57 8.20 9.84 11.48
0.9837 0.3340 0.1390 0.0253 0.8933 0.0824
Ca 
stomach
4 4 1 12 1 4 25 14 16 81
4.94 4.94 1.23 14.81 1.23 4.94 30.86 17.28 19.75
0.0399 .4107 0.4936 0.0022 0.4936 0.0001 0.0001 0.8146 0.0191
Unclear 3 0 1 4 1 1 2 23 16 81
5.88 0.00 1.96 7.84 1.96 1.96 3.92 45.10 31.37
0.0798 0.4936 0.2957 0.4936 0.0002 0.8991 0.1334 0.0003
Vomiting 
Blood
17 5 3 6 2 6 4 13 46 102
16.67 4.90 2.94 5.88 1.96 5.88 3.92 12.75 45.10
0.0085 0.6971 0.3798 0.8579 0.6147 0.0001 0.4864 0.0082 0.0082
Dys-
phagia
1 6 1 5 1 127 6 34 43 224
0.45 2.68 0.45 2.23 0.45 56.70 2.68 15.18 19.20
0.0004 0.2573 0.0860 0.0963 0.1917 0.0001 0.4420 0.0082 0.0082
Total 186 52 85 142 48 199 68 513 397 1690
Endoscopic Diagnosis
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*includes: Reflux oesophagitis, Duodeno-gastric 
(bile) reflux, pyloric stenosis, deformed duodenal 
bulb, oesophageal varices, oesophageal candidiasis, 




This study has demonstrated that dyspepsia is the 
commonest indication for endoscopy in this cohort 
of patients, followed by dysphagia.  We found 
that 62.7% of the patients were referred because of 
dyspepsia, a finding which is in agreement with 
other published findings.  Taye et al. (9) in a review 
of 10,000 endoscopies in Ethiopia between 1979 
and 1994 showed that 59.4% were referred because 
of dyspepsia, whereas in Nigeria in 2009, 61% of 
patients undergoing endoscopy had dyspepsia (10). 
Given that dyspepsia as reflected by the number of 
different definitions in common usage and therefore 
lack of standardisation of the definition especially in 
retrospective reviews, these comparisons should be 
treated with caution.  In addition, some reviewers have 
considered epigastric pain as a separate symptom 
from dyspepsia.  For example, Adful et al. (11) in 
a retrospective and prospective audit of all upper 
gastrointestinal endoscopies performed at the Korle-
Bu Teaching Hospital, Accra, Ghana, involving 6,977 
patients reported that epigastric pain was the leading 
symptom indication for endoscopy in 42.5% followed 
by dyspepsia in 32.8%.  The prevalence of dyspepsia 
in scoped patients can partly be explained by the 
fact that the prevalence of dyspepsia in the general 
population is as high, estimated at about 40% (12). 
Generally, our findings are consistent with the concept 
that dyspepsia calls for various upper gastrointestinal 
pathology that can only be differentiated by upper 
gastrointestinal endoscopy among other sophisticated 
and expensive tests.  It should also be appreciated 
that our clinicians who refer patients are alive to the 
utility of upper gastrointestinal endoscopy in the 
evaluation of patients with dyspeptic symptoms.  This 
could explain the high rate of negative endoscopy 
findings in the patients.  
 Other indications for endoscopy particularly 
dysphagia vary mostly according to age and 
geographical regions.  We found dysphagia to be 
the second, though distant, most frequent reason 
for endoscopy accounting for 13.3%.  Whereas many 
studies on upper gastrointestinal endoscopy on 
dyspeptics have not included dysphagia possibly 
because of the rarity of cancer of the oesophagus in 
their settings or younger age group of the patients 
studied, in the study by Adful et al. (11) with 
comparable mean age (43.6 years) to our patients, 
dysphagia accounted for only 1.7% of the referrals. 
However, their cohort had a mono-modal peak age 
at 30 – 39 years.  Among Ethiopian patients who 
were younger (mean age 36 years) only 2.2% were 
referred because of dysphagia (9) indicating that 
the prevalence of dysphagia as a symptom seems 
to increase with age.  Most patients with dysphagia 
(56.7%) in our cohort were diagnosed at endoscopy 
to have cancer of the oesophagus.  Our patients, 
who on average were young (mean age 45.9 ± 18.9 
years), had a bimodal age distribution peaking at 
26 – 35 years (18.7%) and >65 years (18.3%).  This 
possibly accounted for the high prevalence of cancer 
of oesophagus among those with dysphagia because 
of universal age distribution of this cancer, Kenya 
being one the high cancer of oesophagus areas (13). 
 Normal findings were found in the majority 
(30.4%) of the patients.  This is not surprising as 
the prevalence of non- ulcer dyspepsia has been 
reported to be high (14).  It can therefore be argued 
that the prevalence of normal endoscopy findings 
in symptomatic patients parallel that of non ulcer 
dyspepsia.  This view is supported by many 
publications reporting consistently high prevalence 
of between 41 to 52% of normal endoscopy findings 
among different populations and age groups (11, 15, 
16).  That the majority of patients undergoing upper 
gastrointestinal endoscopy have normal result should 
be of concern as argued by proponents of health cost 
reduction. Endoscopy is an expensive investigation 
(17) to both patient and hospital.   Those who belong 
to this school of thought pose  that to reduce the cost 
of managing dyspeptics, and added to the fact that 
some studies have demonstrated that endoscopy does 
not change the outcome in patients with dyspepsia, 
endoscopy should be reserved for the high risk 
patients or those with alarm symptoms (18).  These 
arguments are borne out by McCormick et al. (19) 
who reported that between 1991 and 1992, the direct 
costs of managing dyspepsia totalled £130 million for 
endoscopies per year in the UK.         
 The world over, peptic ulcer disease (PUD) is 
one of the major diagnoses made on patients with 
dyspepsia.  Among our cohort duodenal ulcer was 
diagnosed in 11.0% and Gastric ulcer in 3.1% only. 
However, among the subset with dyspepsia 14.5% 
had DU and 3.2% GU.  Our findings are at variance 
with those from other countries.  The prevalence of 
PUD  vary from place to place, as H. pylori, which is 
currently recognised as the cause of the majority of 
PUDs, occur with different frequencies in various 
geographical areas.  In Accra Ghana (11) chronic 
duodenal ulcer is seen in 19.6% whereas, UK patients 
with dyspepsia have odds of 27.2 of having PUD 
(20).  In one study from India DU was seen in only 
10.9% (21).  Prevalence of H. pylori has been reported 
by various workers to be decreasing, most markedly 
in the developed countries.  Thus the prevalence of 
PUD will also be lower in these countries compared to 
developing countries.  However, H. pylori still remains 
the main risk factor for PUD globally (22, 23).  Sung 
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et al. (23) in a systematic review of several studies 
reported that one study from Canada involving 1040 
patients found 5.3% prevalence of PUD and another 
from Sweden 4.1%.  Apart from H. pylori, data on 
prevalence of PUD may vary based on demographic 
differences between populations studied and the 
definition of dyspepsia as used by the researchers. 
In this review, H. pylori testing was not done in any 
of the patients.
 All the patients were referred for upper 
gastrointestinal endoscopy with various symptoms. 
Slightly below a third of all patients (30.4%) had 
normal upper gastrointestinal findings at endoscopy. 
This means that symptomatology alone may not 
be an accurate predictor of upper gastrointestinal 
endoscopy finding.  This argument is supported by 
the report of Agbakwuru et al. (24) that only 33.9% of 
67.6% of clinical PUD diagnosis had PUD, a positive 
predictive value of 36%.  Similarly, Kolk (16) found 
an odds of 3.3 (95%CI; 1.7 – 8.1) for PUD using 
logistic regression analysis of 172 patients referred 
for endoscopy with dyspepsia.  These data suggest 
that treating PUD should not rely on symptoms, even 
though for reasons we may not be able to explain, our 
Loglinear regression model results suggest otherwise. 
However, dysphagia and clinical diagnosis of Cancer 
of oesophagus are much more predictive of endoscopy 
diagnosis (p<0.001). 
 LIMITATIONS
This study relied on single observer, the endoscopist, 
for diagnosis as recorded in the charts, whereas, 
the accuracy of endoscopy diagnoses is known to 
be dependent on the experience of the endoscopist. 
Endoscopy is an expensive procedure thus most 
patients cannot access.  Hence our results may not 
stand the test of generalisation, as only those who 
could pay underwent the procedure.
 CONCLUSION
Patients referred for upper GI endoscopy during the 
period under review represented all age groups with 
median of 44 years.  They comprised almost similar 
numbers of males and females. 
 The main reason for referrals for endoscopy was 
dyspepsia, however the majority of such patients 
had normal findings. Dysphagia had a significant 
predictive relationship with cancer of the oesophagus.
RECOMMENDATION
We recommend that patients with dyspepsia in low-
resource settings should be thoroughly scrutinised 
and only those at high risk and/or with alarm 
symptoms should be subjected to endoscopy.  
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